OMB-OMBofatumumabteriflunomidepwRMSrelapsing multiple sclerosis
…receiving continuous ofatumumab in ASCLEPIOS I/II and ALITHIOS (OMB-OMB) versus delayed treatment (TER-OMB) for 6mCDW (21.1% vs 24.8%, …
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: OMB-OMB ×
OMB-OMB
This funder is selected. Its supporting articles are shown below.